Suzetrigine selectively inhibits the NaV1.8 pain-signaling pathway in the peripheral nervous system and provides effective ...

The novel formulation of rizatriptan and meloxicam (Symbravo, Axome Therapeutics) is for the acute treatment of migraine with ...

The European Medicines Agency’s positive opinion for ivermectin-albendazole for treating soil-transmitted helminth infections ...

The reassessment of Leqembi’s safety data follows the agency’s previous recommendation of the drug for use in the EU.

The European Medicines Agency has recommended three new medicines to treat breast and cervical cancer and ...

Marketing authorization for the first EU vaccine to protect adolescents against chikungunya has been expedited for its public ...

New research showed some long COVID patients get symptom relief by taking an extended course of Paxlovid. Data are ...

A pilot trial will assess whether concentrated bone marrow aspirate can prevent inflammation and reduce postsurgery pain and ...

Researchers have made strides creating strong, long-lasting imitation muscle as science fiction slowly evolves into fact.

The European Medicines Agency (EMA) has recommended granting marketing authorization for the pneumococcal vaccine Capvaxive (pneumococcal polysaccharide conjugate vaccine [21-valent]) intended to ...

Influenza is a common disease that occurs in yearly epidemics throughout the world. Although the majority of infected individuals will exhibit a self-limited acute febrile illness or remain ...

Everything's disrupted.’ It's not quite that simple.” Author, executive advisor, and chief futurist at Futurist.com, Nikolas Badminton, talks healthcare in 2050.